Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex and Brain: The Role of Sex Chromosomes and Hormones in Brain Development and Parkinson's Disease. | Cells | 2023 | 37296608 | PubTator, text mining | PubMed |
| Clinical Evolution of Tardive Cervical Dystonia from Antecollis to Retrocollis. | Cureus | 2023 | 37284375 | PubTator, text mining | PubMed |
| Deuterium in drug discovery: progress, opportunities and challenges. | Nat Rev Drug Discov | 2023 | 37277503 | PubTator, text mining | PubMed |
| Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight. | Front Neurosci | 2023 | 37274201 | PubTator, text mining | PubMed |
| Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity. | Stem Cell Rev Rep | 2023 | 37273171 | PubTator, text mining | PubMed |
| The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA sequence. | Front Oncol | 2023 | 37265785 | PubTator, text mining | PubMed |
| Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic. | J Mov Disord | 2023 | 37258279 | PubTator, text mining | PubMed |
| De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime. | J Med Chem | 2023 | 37256819 | PubTator, text mining | PubMed |
| Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects. | Cureus | 2023 | 37255893 | PubTator, text mining | PubMed |
| Sleep Dysfunction in Huntington's Disease: Impacts of Current Medications and Prospects for Treatment. | J Huntingtons Dis | 2023 | 37248911 | PubTator, text mining | PubMed |
| Consensus Ensemble Multitarget Neural Network Model of Anxiolytic Activity of Chemical Compounds and Its Use for Multitarget Pharmacophore Design. | Pharmaceuticals (Basel) | 2023 | 37242513 | PubTator, text mining | PubMed |
| Gene Therapy Using Efficient Direct Lineage Reprogramming Technology for Neurological Diseases. | Nanomaterials (Basel) | 2023 | 37242096 | PubTator, text mining | PubMed |
| Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer's Disease. | Life (Basel) | 2023 | 37240740 | PubTator, text mining | PubMed |
| The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson's Disease-Associated Neurodegeneration. | Int J Mol Sci | 2023 | 37239960 | PubTator, text mining | PubMed |
| Occurrence and Health Effects of Hexabromocyclododecane: An Updated Review. | Toxics | 2023 | 37235223 | PubTator, text mining | PubMed |
| Effects of exercise of different intensities on withdrawal symptoms among people with substance use disorder: a systematic review and meta-analysis. | Front Physiol | 2023 | 37234417 | PubTator, text mining | PubMed |
| Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features. | Nat Commun | 2023 | 37225691 | PubTator, text mining | PubMed |
| Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial. | Lancet Neurol | 2023 | 37210099 | PubTator, text mining | PubMed |
| Recent Medicinal Chemistry Studies against Neurodegenerative Diseases. | Curr Neuropharmacol | 2023 | 37203192 | PubTator, text mining | PubMed |
| Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia. | Neuropsychiatr Dis Treat | 2023 | 37193547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=17